|
Administration
May be taken with or without food.
|
|
Special Precautions
Elderly. Pregnancy and lactation. Patient Counselling This drug may cause drowsiness or dizziness, if affected, do not drive or operate machinery.
|
|
Adverse Reactions
Significant: Dizziness, drowsiness, thrombocytopenia, leucopenia, hypersensitivity and anaphylactoid reactions (e.g. hives, rash, itching, eczema), shock, jaundice. Rarely, liver dysfunction.
Gastrointestinal disorders: Constipation, dry mouth, diarrhoea, nausea, vomiting, heartburn, abdominal pain, belching, sensation of abdominal enlargement, taste abnormality.
Investigations: Increased AST, ALT, alkaline phosphatase, or BUN levels.
|
|
CIMS Class
|
|
ATC Classification
A02BX14 - rebamipide ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
|
Sign Out
